Steven Halper
Stock Analyst at Cantor Fitzgerald
(3.09)
# 989
Out of 4,829 analysts
72
Total ratings
51.67%
Success rate
8.98%
Average return
Main Sectors:
Stocks Rated by Steven Halper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $5.98 | +83.95% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $5.56 | +439.57% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $4.52 | +253.98% | 4 | Sep 14, 2023 | |
| AMWL American Well | Initiates: Overweight | $300 | $7.21 | +4,060.89% | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | $82 → $85 | $96.66 | -12.06% | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $27.46 | - | 7 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | $504 | $152.05 | +231.47% | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | $390 | $8.13 | +4,697.05% | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $9 → $8 | $9.31 | -14.07% | 6 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | $135 → $145 | $7.35 | +1,872.79% | 8 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $150 → $185 | $5.58 | +3,215.41% | 5 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $245 → $255 | $315.74 | -19.24% | 2 | Feb 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $345 → $400 | $252.86 | +58.19% | 2 | Feb 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $26.05 | +22.84% | 1 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $83 | $62.87 | +31.22% | 8 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $5.98
Upside: +83.95%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $5.56
Upside: +439.57%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $4.52
Upside: +253.98%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: $300
Current: $7.21
Upside: +4,060.89%
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: $82 → $85
Current: $96.66
Upside: -12.06%
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $27.46
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: $504
Current: $152.05
Upside: +231.47%
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: $390
Current: $8.13
Upside: +4,697.05%
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: $9 → $8
Current: $9.31
Upside: -14.07%
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: $135 → $145
Current: $7.35
Upside: +1,872.79%
Feb 21, 2020
Reiterates: Overweight
Price Target: $150 → $185
Current: $5.58
Upside: +3,215.41%
Feb 6, 2020
Reiterates: Overweight
Price Target: $245 → $255
Current: $315.74
Upside: -19.24%
Feb 5, 2020
Reiterates: Overweight
Price Target: $345 → $400
Current: $252.86
Upside: +58.19%
Jan 9, 2020
Initiates: Overweight
Price Target: $32
Current: $26.05
Upside: +22.84%
Dec 17, 2018
Maintains: Overweight
Price Target: $73 → $83
Current: $62.87
Upside: +31.22%